Publications

List of publications

2023

• SRSF2 plays an unexpected role as reader of m5C on mRNA, linking epitranscriptomics to cancer. Ma, H., Bizet, M., Soares Da Costa, C., Murisier, F., James de Bony, E., Wang, M., Yoshimi, A., Lin, K., Riching, K., Wang, X., Beckman, J., Arya, S., Droin, N., Calonne, E., Hassabi, B., Zhang, O., Li, A., Putmans, P., Malbec, L., Hubert, C., Lan, J., Mies, F., Yang, Y., Solary, E., Daniels, D., Gupta, Y., Deplus, R., Abdel-Wahab, O., Yang, Y., Fuks, F. (2023)
• Methylglyoxal: a novel upstream regulator of DNA methylation. Dube, G., Tiamiou, A., Bizet, M., Boumahd, Imène Gasmi, I., Crake, R., Bellier, J., Nokin, M., Calonne, E., Deplus, R., Wissocq, T., Peulen, O., Castronovo, V., Fuks, F. & Bellahcène, A. (2023)

2022

• Cancer epitranscriptomics in a nutshell. Primac, I., Penning, A., Fuks, F. (2022)
• Improving Infinium MethylationEPIC data processing: re-annotation of enhancers and long noncoding RNA genes and benchmarking of normalization methods. Bizet, M., Defrance, M., Calonne, E., Bontempi, G., Sotiriou, C., Fuks, F., & Jeschke, J. (2022)
• Mesp1 controls the chromatin and enhancer landscapes essential for spatiotemporal patterning of early cardiovascular progenitors. Lin, X., Swedlund, B., Ton, M.-L. N., Ghazanfar, S., Guibentif, C., Paulissen, C., Baudelet, E., Plaindoux, E., Achouri, Y., Calonne, E., Dubois, C., Mansfield, W., Zaffran, S., Marioni, J. C., Fuks, F., Göttgens, B., Lescroart, F., & Blanpain, C. (2022)
• Why novel mRNA modifications are so challenging and what we can do about it. Penning, A., Jeschke, J., & Fuks, F. (2022).
• Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Ait-Ammar, A., Santangelo, M., Plant, E., Douce, V. L., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Passaes, C. P. B., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., & Van Lint, C. (2022)

2021

• Downregulation of the FTO m⁶A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors. Jeschke, J., Collignon, E., Al Wardi, C., Krayem, M., Bizet, M., Jia, Y., Garaud, S., Wimana, Z., Calonne, E., Hassabi, B., Morandini, R., Deplus, R., Putmans, P., Dube, G., Singh, N. K., Koch, A., Shostak, K., Rizzotto, L., Ross, R. L., Desmedt, C., Bareche, Y., Rothé, F., Lehmann-Che, J., Duterque-Coquillaud, M., Leroy, X., Menschaert, G., Teixeira, L., Guo, M., Limbach, P. A., Close, P., Chariot, A., Leucci, E., Ghanem, G., Yuan, B., Willard-Gallo, K., Sotiriou, C., Marine, J.-C., & Fuks, F. (2021)
• The chromatin remodelling protein LSH/HELLS regulates the amount and distribution of DNA hydroxymethylation in the genome. De Dieuleveult, M., Bizet, M., Colin, L., Calonne, E., Bachman, M., Li, C., Stancheva, I., Miotto, B., Fuks, F. , & Deplus, R. (2021)

2020

• Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation. Lan, J., Rajan, N., Bizet, M., Penning, A., Singh, N. K., Guallar, D., Calonne, E., Li Greci, A., Bonvin, E., Deplus, R., Hsu, P. P., Nachtergaele, S., Ma, C., Song, R., Fuentes-Iglesias, A., Hassabi, B., Putmans, P., Mies, F., Menschaert, G., Wong, J. J. L., Wang, J., Fidalgo, M., Yuan, B., & Fuks, F. (2020)

2019

• Monocytes undergo multi-step differentiation in mice during oral infection by Toxoplasma gondii. Detavernier, A., Azouz, A., Shehade, H., Splittgerber, M., Van Maele, L., Nguyen, M., Thomas, S., Achouri, Y., Svec, D., Calonne, E., Fuks, F. , Oldenhove, G., & Goriely, S. (2019)
• EOMES interacts with RUNX3 and BRG1 to promote innate memory cell formation through epigenetic reprogramming. Istaces, N., Splittgerber, M., Lima Silva, V., Nguyen, M., Thomas, S., Le, A., Achouri, Y., Calonne, E., Defrance, M., Fuks, F. , Goriely, S., & Azouz, A. (2019)
• TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression. Bonvin, E., Radaelli, E., Bizet, M., Luciani, F., Calonne, E., Putmans, P., Nittner, D., Singh, N. K., Santagostino, S. F., Petit, V., Larue, L., Marine, J.-C., & Fuks, F. (2019)

2018

• Immunity drives TET1 regulation in cancer through NF-κB. Collignon, E., Canale, A., Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., Bouchat, S., Hubert, P., Van Lint, C.,Yull, F., Sotiriou, C., Willard-Gallo, K., Noël, A., & Fuks, F.
• Comprehensive identification of long noncoding RNAs in colorectal cancer. Bony, E. J., Bizet, M., Van Grembergen, O., Hassabi, B., Calonne, E., Putmans, P.,Bontempi, G., & Fuks, F
• Positioning Europe for the EPITRANSCRIPTOMICS challenge. Jantsch, M. M., Quattrone, A., O’Connell, M., Helm, M., Frye, M., Macias-Gonzales, M.,Ohman, M., Ameres, S., Willems, L., Fuks, F., Oulas, A., Vanacova, S., Nielsen, H., Bousquet-Antonelli, C., Motorin, Y., Roignant, J.-Y., Balatsos, N., Dinnyes, A., Baranov, P., Kelly, V., Lamm, A., Rechavi, G., Pelizzola, M., Liepins, J., Holodnuka Kholodnyuk, I., Zammit, V., Ayers, D., Drablos, F., Dahl, J. A., Bujnicki, J. M., Jeronimo, C., Almeida, R., Neagu, M., Costache, M., Bankovic, J., Banovic, B., Kyselovic, J., Valor, L. M., Selbert, S., Pir, P., Demircan, T., Cowling, V., Schäfer, M., Rossmanith, W., Lafontaine, D., David, A., Carre, C., Lyko, F., Schaffrath, R., Schwartz, S., Verdel, A., Klungland, A., Purta, E., Timotijevic, G., Cardona, F., Davalos, A., Ballana, E., O Carroll, D., Ule, J., & Fray, R
• The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes. Serroukh, Y., Gu-Trantien, C., Hooshiar Kashani, B., Defrance, M., Vu Manh, T.-P., Azouz, A., Detavernier, A., Hoyois, A., Das, J., Bizet, M., Pollet, E., Tabbuso, T., Calonne, E., van Gisbergen, K., Dalod, M., Fuks, F., Goriely, S., & Marchant, A.

2017

• Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. Wang, Y., He, T., Herman, J. J., Linghu, E., Yang, Y., Fuks, F., Zhou, F., Song, L., &Guo, M.
• Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. Wang, Y., He, T., Herman, J. J., Linghu, E., Yang, Y., Fuks, F., Zhou, F., Song, L., &Guo, M.
• Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma. Guo, Y., Peng, Y., Gao, D., Zhang, M., Yang, W., Linghu, E., Herman, J. J., Fuks, F., Dong, G., & Guo, M.
• DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. Jeschke, J., Bizet, M., Desmedt, C., Calonne, E., Dedeurwaerder, S., Garaud, S., Koch, A., Larsimont, D., Salgado, R., Van den Eynden, G., Willard-Gallo, K., Bontempi, G., Defrance, M., Sotiriou, C., & Fuks, F
• Meeting Report of the Fifth International Cancer Epigenetics Conference in Beijing, China, October 2016. Gao, D., Herman, J. G., Cui, H., Jen, J., Fuks, F., Brock, M. V., Ushijima, T., Croce, C., Akiyama, Y., & Guo, M.
• Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development. Gao, D., Han, Y., Yang, Y., Herman, J. G., Linghu, E., Zhan, Q., Fuks, F., Lu, Z. J., & Guo, M.
• FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders. Garaud, S., Roufosse, F., De Silva, P., Gu-Trantien, C., Lodewyckx, J. N., Duvillier, H., Dedeurwaerder, S., Bizet, M., Defrance, M., Fuks, F., Bex, F., & Willard-Gallo, K.

2016

• Portraying breast cancers with long noncoding RNAs. Van Grembergen, O., Bizet, M., de Bony, E. J., Calonne, E., Putmans, P., Brohée, S., Olsen, C., Guo, M., Bontempi, G., Sotiriou, C., Defrance, M., & Fuks, F
• Portraits of TET-mediated DNA hydroxymethylation in cancer. Jeschke, J., Collignon, E., & Fuks, F.
• Transcriptome-wide distribution and function of RNA hydroxymethylcytosine. Delatte, B., Wang, F., Vo Ngoc, L., Collignon, E., Bonvin, E., Deplus, R., Calonne, E., Hassabi, B., Putmans, P., Awe, S., Wetzel, C., Kreher, J., Soin, R., Creppe, C., Limbach, P. A., Gueydan, C., Kruys, V., Brehm, A., Minakhina, S., Defrance, M., Steward, R., & Fuks, F
• Expanding the RNA alphabet: The expanding world of mRNA modifications Delatte, B., & Fuks, F
• The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent. Brenner, C., Luciani, J., Bizet, M., Ndlovu, M. N., Josseaux, E., Dedeurwaerder, S., Calonne, E., Putmans, P., Cartron, P. F., Defrance, M., Fuks, F., & Deplus, R

2015

• MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. Denis, H., Van Grembergen, O., Delatte, B., Dedeurwaerder, S., Putmans, P., Calonne, E., Rothé, F., Sotiriou, C., Fuks, F., & Deplus, R.
• Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress. Delatte, B., Jeschke, J., Defrance, M., Bachman, M., Creppe, C., Calonne, E., Bizet, M., Deplus, R., Marroquí, L., Libin, M., Ravichandran, M., Mascart, F., Eizirik, D. L., Murrell, A., Jurkowski, T. P., & Fuks, F.
• Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion. Larsimont, J.-C., Kass, Y. K., Sanchez Danes, A., Sukumaran, V., Defrance, M., Delatte, B., Liagre, M., Baatsen, P., Marine, J.-C., Lippens, S., Guerin, C., Del Marmol, V., Vanderwinden, J.-M., Fuks, F., & Blanpain, C.
• 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer Uribe-Lewis, S., Stark, R., Carroll, T., Dunning, M. J., Bachman, M., Ito, Y., Stojic, L., Halim, S., Vowler, S. L., Lynch, A. G., Delatte, B., de Bony, E. J., Colin, L., Defrance, M., Krueger, F., Silva, A. L., ten Hoopen, R., Ibrahim, A. E., Murrell, A., & Fuks, F.
• Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth. Yang, D., Cao, B., Zhang, M., Han, W., Herman, J. J., Fuks, F., Zhao, Y., & Guo, M.

2014

• DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Rampal, R., Alkalin, A., Madzo, J., Vasanthakumar, A., Pronier, E., Patel, J., Li, Y., Ahn, J., Abdel-Wahab, O., Shih, A., Lu, C., Ward, P. S., Tsai, J. J., Hricik, T., Tosello, V., Tallman, J., Zhao, X., Daniels, D., Dai, Q., Ciminio, L., Aifantis, I., He, C., Fuks, F., Tallman, M. S., Ferrando, A., Nimer, S., Paietta, E., Thompson, C. C., Licht, J. D., Mason, C. C., Godley, L. A., Melnick, A., Figueroa, M. E., & Levine, R. L.
• A comprehensive overview of Infinium HumanMethylation450 data processing . Dedeurwaerder, S., Defrance, M., Bizet, M., Calonne, E., Bontempi, G., & Fuks, F.
• DNA methylome profiling beyond promoters – taking an epigenetic snapshot of the breast tumor microenvironment. Jeschke, J., Collignon, E., & Fuks, F.
• Regulation of DNA Methylation Patterns by CK2-Mediated Phosphorylation of Dnmt3a. Deplus, R., Blanchon, L., Rajavelu, A., Boukaba, A. H., Defrance, M., Luciani, J., Rothé, F., Dedeurwaerder, S., Denis, H., Brinkman, A. B., Simmer, F., Müller, F., Bertin, B., Berdasco, M., Putmans, P., Calonne, E., Litchfield, D. D., De Launoit, Y., Jurkowski, T. P., Stunnenberg, H. H., Bock, C., Sotiriou, C., Fraga, M. F., Esteller, M., Jeltsch, A., & Fuks,F.
• TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells. Langlois, T., Da Costa Reis Monte-Mor, B., Lenglet, G., Droin, N., Marty, C., Le Couédic, J. P., Almire, C., Auger, N., Mercher, T., Delhommeau, F., Christensen, J., Helin, K., Debili, N., Fuks, F., Bernard, O. A., Solary, E., Vainchenker, W., & Plo, I.
• SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., Brohée, S., Salmon, I., Dubois, C., Del Marmol, V., Fuks, F., Beck, B., & Blanpain, C.
• Playing TETris with DNA modifications. Delatte, B., Deplus, R., & Fuks, F.
• The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Solary, É., Bernard, O., Tefferi, A., Fuks, F., & Vainchenker, W.
• Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state. Milenkovic, D., Vanden Berghe, W., Boby, C., Leroux, C., Declerck, K., Szarc vel Szic, K., Heyninck, K., Laukens, K., Bizet, M., Defrance, M., Dedeurwaerder, S., Calonne, E., Fuks, F., Haegeman, G., Haenen, G. R. M. M. G., Bast, A., & Weseler, A. R.
• Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylation. Deplus, R., Denis, H., Putmans, P., Calonne, E., Fourrez, M., Yamamoto, K., Suzuki, A., & Fuks, F.
• Playing TETris with DNA modifications. Delatte, B., Deplus, R., & Fuks, F.

2013

• Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer. Yan, W., Wu, K., Herman, J. J., Brock, M. M., Fuks, F., Yang, L., Zhu, H., Li, Y., Yang, Y., & Guo, M.
• TET proteins: on the frenetic hunt for new cytosine modifications. Delatte, B., & Fuks, F.
• TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. Deplus, R., Delatte, B., Schwinn, M. K., Defrance, M., Méndez, J., Murphy, N., Dawson, M. A., Volkmar, M., Putmans, P., Calonne, E., Shih, A. H., Levine, R. L., Bernard, O., Mercher, T., Solary, E., Urh, M., Daniels, D., & Fuks, F.

2012

• DNA methylation markers for breast cancer prognosis: Unmasking the immune component. Dedeurwaerder, S., & Fuks, F.
• Aberrant Promoter Methylation and Expression of UTF1 during Cervical Carcinogenesis. Guenin, S., Mouallif, M., Deplus, R., Lampe, X., Krusy, N., Calonne, E., Delbecque, K., Kridelka, F., Fuks, F., Ennaji, M. M., & Delvenne, P. O.
• The histone demethylase Kdm3a is essential to progression through differentiation. Herzog, M., Josseaux, E., Dedeurwaerder, S., Calonne, E., Volkmar, M., & Fuks,F.
• DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. Volkmar, M., Dedeurwaerder, S., Andrade Da Cunha, D., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo Esteve, M., Naamane, N., Del Guerra, S., Masini, M., Bugliani, M., Marchetti, P., Cnop, M., Eizirik, D. L., & Fuks, F.

2011

• DNA methylation profiling reveals a predominant immune component in breast cancers. Dedeurwaerder, S., Desmedt, C., Calonne, E., Singhal, S. K., Haibe-Kains, B., Defrance, M., Michiels, S., Volkmar, M., Deplus, R., Luciani, J., Lallemand, F., Larsimont, D., Toussaint, J., Haussy, S., Rothé, F., Rouas, G., Metzger, O., Majjaj, S., Saini, K., Putmans, P., Hames, G., Van Baren, N., Coulie, P. G., Piccart-Gebhart, M., Sotiriou, C., & Fuks, F.
• Evaluation of the Infinium Methylation 450K technology. Dedeurwaerder, S., Defrance, M., Calonne, E., Denis, H., Sotiriou, C., & Fuks, F.
• Unravelling the epigenomic dimension of breast cancers. Dedeurwaerder, S., Fumagalli, D., & Fuks, F.
• Regulation of mammalian DNA methyltransferases: a route to new mechanisms. Denis, H., Ndlovu, M. N., & Fuks, F.
• Exposing the DNA methylome iceberg. Ndlovu, M. N., Denis, H., & Fuks, F.

2010

• A cancer biologist marvels at how key gene regulators are still revealing hidden talents. Fuks, F.

2009

• Functional connection between deimination and deacetylation of histones. Denis, H., Deplus, R., Putmans, P., Yamada, M., Métivier, R., & Fuks, F.
• Atonal homolog 1 is a tumor suppressor gene. Bossuyt, W., Kazanjian, A., De Geest, N., Van Kelst, S., De Hertogh, G., Geboes, K., Boivin, G. P., Luciani, J., Fuks, F., Chuah Lay Khim, M., VandenDriessche, T., Marynen, P., Cools, J., Shroyer, N. F., & Hassan, B. A.

2008

• De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Epsztejn-Litman, S., Feldman, N., Abu-Remaileh, M., Shufaro, Y., Gerson, A., Ueda, J., Deplus, R., Fuks, F., Shinkai, Y., Cedar, H., & Bergman, Y.
• Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. Firlej, V., Ladam, F., Brysbaert, G., Dumont, P., Fuks, F., De Launoit, Y., Benecke, A., & Chotteau-Lelievre, A.
• MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks. Morey, L., Brenner, C., Fazi, F., Villa, R., Gutierrez, A., Buschbeck, M., Nervi, C., Minucci, S., Fuks, F., & Di Croce, L.
• The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Nuytten, M., Beke, L., Van Eynde, A., Ceulemans, H., Beullens, M., Van Hummelen, P., Fuks, F., & Bollen, M.
• La biologie et la médecine a l’heure de l’epigénétique. Bulletin et mémoires de l’Académie royale de médecine de Belgique. Fuks, F.

2007

• A Methylation Rendezvous: Reader Meets Writers. Brenner, C., & Fuks, F.
• Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia. Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Viré, E., Nomdedeu, J. F., Jenuwein, T., Pelicci, P. G., Minucci, S., Fuks, F., Helin, K., & Di Croce, L.
• Identification of epigenetically silenced genes in tumor endothelial cells. Hellebrekers, D. D., Melotte, V., Viré, E., Langenkamp, E., Molema, G., Fuks, F., Herman, J. J., Van Criekinge, W., Griffioen, A. A., & van Engeland, M.
• Viral oncoproteins target the DNA methyltransferases. Burgers, W. A., Blanchon, L., Pradhan, S., De Launoit, Y., Kouzarides, T., & Fuks, F.

2006

• Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Hellebrekers, D. M. E. I., Castermans, K., Viré, E., Dings, R. P. M., Hoebers, N. T. H., Mayo, K. H., Oude Egbrink, M. G. A., Molema, G., Fuks, F., van Engeland, M., & Griffioen, A. W.
• The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Bernard, D., Gil, J., Dumont, P., Rizzo, S., Monte, D., Quatannens, B., Hudson, D., Visakorpi, T., Fuks, F., & De Launoit, Y.
• The Polycomb group protein EZH2 directly controls DNA methylation. Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M. F., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., De Launoit, Y., & Fuks, F.
• Angiostatic activity of DNA methyltransferase inhibitors. Hellebrekers, D. M. E. I., Jair, K.-W., Viré, E., Eguchi, S., Hoebers, N. T. H., Fraga, M. F., Esteller, M., Fuks, F., Baylin, S. B., van Engeland, M., & Griffioen, A. W.
• The view from the biochemist Comment on “Chromatin code, local non-equilibrium dynamics, and the emergence of transcription regulatory programs” by Arndt Benecke. Fuks, F.
• DNA Methyltransferases: Facts, Clues, Mysteries. Brenner, C., & Fuks, F.

2005

• DNA methylation and histone modifications: teaming up to silence genes. Fuks, F.
• Myc represses transcription through recruitment of DNA methyltransferase corepressor. Brenner, C., Deplus, R., Didelot, C., Loriot, A., Viré, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T., Pelicci, P. G., Amati, B., Kouzarides, T., De Launoit, Y., Di Croce, L., & Fuks, F.

2004

• Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. Espada, J., Ballestar, E., Fraga, M. F., Villar-Garea, A., Juarranz, A., Stockert, J. C., Robertson, D., Fuks, F., & Esteller, M.
• MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Laduron, S., Deplus, R., Zhou, S., Kholmanskikh, O., Godelaine, D., De Smet, C., Hayward, S. D., Fuks, F., Boon, T., & De Plaen, E.

2003

• EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Hughes-Davies, L., Huntsman, D., Ruas, M., Fuks, F., Bye, J., Chin, S.-F., Milner, J., Brown, L. A., Hsu, F., Gilks, B., Nielsen, T., Schulzer, M., Chia, S., Ragaz, J., Cahn, A., Linger, L., Ozdag, H., Cattaneo, E., Jordanova, E. S., Schuuring, E., Yu, D. S., Venkitaraman, A., Ponder, B., Doherty, A., Aparicio, S., Bentley, D., Theillet, C., Ponting, C. P., Caldas, C., & Kouzarides, T.
• The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Fuks, F., Hurd, P. J., Deplus, R., & Kouzarides, T.
• Les méthyltransférases de l’ADN : du remodelage de la chromatine au cancer. Fuks, F.
• The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. Fuks, F., Hurd, P. J., Wolf, D., Nan, X., Bird, A. P., & Kouzarides, T.

2002

• Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Deplus, R., Brenner, C., Burgers, W. A., Putmans, P., Kouzarides, T., De Launoit, Y., & Fuks, F.
• DNA methyltransferases get connected to chromatin. Burgers, W. A., Fuks, F., & Kouzarides, T.
• Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., Minucci, S., & Pelicci, P. G.

2001

• Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. Fuks, F., Burgers, W. A., Godin, N., Kasai, M., & Kouzarides, T.

2000

• The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase. Milner, J., Fuks, F., Hughes-Davies, L., & Kouzarides, T.
• DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., & Kouzarides, T.

1999

• Atypical nucleoprotein complexes mediate CRE-dependent regulation of the early promoter of minute virus of mice. Perros, M., Fuks, F., Kherrouche, Z., & Rommelaere, J.

1998

• BRCA2 associates with acetyltransferase activity when bound to P/CAF. Fuks, F., Milner, J., & Kouzarides, T.
• Opposite Transcriptional Effects of Cyclic AMP-Responsive Elements in Confluent or p27KIP-Overexpressing Cells versus Serum-Starved or Growing Cells. Deleu, L., Fuks, F., Spitkovsky, D., Hörlein, R., Faisst, S., & Rommelaere, J.

1996

• ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors. Fuks, F., Deleu, L., Dinsart, C., Rommelaere, J., & Faisst, S.